|Day Low/High||36.54 / 37.23|
|52 Wk Low/High||27.93 / 43.71|
Coach (COH) stock coverage was started with a 'buy' rating at CLSA this afternoon.
The new Cochlear™ Nucleus® Profile Implant with Slim Modiolar Electrode (CI532) is designed to preserve hearing structures, boost hearing performance and is easy for surgeons to use
Cramer sees Anadarko Petroleum profiting and Coach returning to its former glory.
Worried about a bad event? There will be money coming off the sidelines afterward. Be prepared to buy on weakness.
Shares of Coach were higher Monday on word that Piper Jaffray sees the stock moving toward growth from recovery.
Coach (COH) stock is moving toward growth from a period of recovery, Piper Jaffray said in a note on Monday.
The Cochlear™ Nucleus® Hybrid™ Implant System now covered by Anthem®; Hybrid Hearing now available to all with functional low frequency hearing
Shares of the luxury-fashion retailer continued to fall out of vogue on Wednesday.
The S&P 500 and Dow Jones Industrial Average turned negative in the afternoon session as crude endured another selloff.
BK Asset Management managing director Boris Schlossberg and Susquehanna Financial Group head of derivative strategy Stacey Gilbert discussed the luxury retail space on CNBC.
Stocks lose highs by mid-afternoon Wednesday as a selloff in crude resumes.
Coach (COH) was downgraded to a 'underweight' from 'equal weight' at Morgan Stanley earlier today.
The luck could be turning for shareholders in casino and resort stocks.
Morgan Stanley is questioning whether luxury goods company Coach has a turnaround plan that will work.
Morgan Stanley claims that the apparent turnaround at Coach (COH) is essentially not real, which could be a reason to sell the stock, Jim Cramer says.
Stocks add to slight gains on Wednesday as Wall Street stabilizes after three days of extreme swings.
Coach (COH) stock was cut to 'underweight' at Morgan Stanley as the firm questions a 'sustainable turnaround.'
Coach taps into its 75-year old history for its spring 2017 women's line.
Handbag maker Coach is working to bolster its cool factor, this time by opening up a fancy pop-up store during fashion week.
Cochlear receives FDA approval on new hearing device that combines best-in-class hearing performance with a simple, discreet design
A roundup of this week's payout hikes and a look ahead at next week's key dates.
Shares of luxury handbag maker Coach (COH) have rebounded this year, but the gains aren't over, thanks to the company's transformation plan.
Wall Street ended the week just points from new records as disappointing retail data on Friday failed to overshadow a blockbuster Thursday.
J.C. Penney, Macy's, Nordstrom and others all made their investors very happy, but there were still reasons to be cautious.
J.C. Penney's focus on low prices and affordable private-label products continues to serve it well.
Kohl's has beaten earnings estimates, but the company has other challenges.